Aptose Biosciences is a clinical-stage biotechnology company developing differentiated therapies to address unmet medical needs in oncology, with a particular ...
People also ask
Is APTO stock a good buy?
Who are the shareholders of Apto?
Aptose Biosciences is a clinical-stage biotechnology company committed to developing first-in-class targeted agents to treat life-threatening cancers.
People also search for
Find the latest institutional holdings data for Aptose Biosciences, Inc. Common Shares (APTO) including shareholders, ownership summaries, ...
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
Aptose Biosciences (APTO) Investor Presentation - Slideshow · SA TranscriptsThu, Apr. 14, 2022. Aptose Biosciences Inc. (APTO) CEO Dr. William G. Rice on Q4 ...
Find the latest Aptose Biosciences Inc. (APTO) stock quote, history, news and other vital information to help you with your stock trading and investing.
Mar 26, 2024 · Susan Pietropaolo - Managing Director-Corporate Communications & Investor Relations William Rice - Chairman, President & Chief Executive ...